Literature DB >> 11247865

Employment, work disability, and work days lost in patients with ankylosing spondylitis: a cross sectional study of Dutch patients.

A Boonen1, A Chorus, H Miedema, D van der Heijde, H van der Tempel, S van der Linden.   

Abstract

OBJECTIVE: To evaluate employment status, work disability, and work days lost in patients with ankylosing spondylitis (AS).
METHODS: A questionnaire was sent to 709 patients with AS aged 16-60. The results of 658 of the patients could be analysed.
RESULTS: After adjustment for age, labour force participation was decreased by 15.4% in male patients and 5.2% in female patients compared with the general Dutch population. Work disability (all causes) was 15.7% and 16.9% higher than expected in the general population for male and female patients respectively. In particular, the proportion of those with a partial work disability pension was increased. Patients with a paid job lost 5.0% of work days as the result of having AS, accounting for a mean of 10.1 days of sick leave due to AS per patient per year in addition to the national average of 12.3 unspecified days of sick leave.
CONCLUSION: This study on work status in AS provides data adjusted for age and sex, and the differences from the reference population were significant. The impact of AS on employment and work disability is considerable. Work status in patients with AS needs more attention as an outcome measure in future research.

Entities:  

Mesh:

Year:  2001        PMID: 11247865      PMCID: PMC1753602          DOI: 10.1136/ard.60.4.353

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  49 in total

1.  Labour force participation among patients with rheumatoid arthritis.

Authors:  A M Chorus; H S Miedema; C J Wevers; S van Der Linden
Journal:  Ann Rheum Dis       Date:  2000-07       Impact factor: 19.103

2.  Working ability of 76 patients with ankylosing spondylitis.

Authors:  K Lehtinen
Journal:  Scand J Rheumatol       Date:  1981       Impact factor: 3.641

3.  Differences between respondents and non-respondents in a population-based cardiovascular disease study.

Authors:  M H Criqui; E Barrett-Connor; M Austin
Journal:  Am J Epidemiol       Date:  1978-11       Impact factor: 4.897

4.  Work disability in rheumatoid arthritis: effects of disease, social, and work factors.

Authors:  E Yelin; R Meenan; M Nevitt; W Epstein
Journal:  Ann Intern Med       Date:  1980-10       Impact factor: 25.391

5.  Clinical trial enrollers vs. nonenrollers: the Cardiac Arrhythmia Suppression Trial (CAST) Recruitment and Enrollment Assessment in Clinical Trials (REACT) project.

Authors:  L Gorkin; E B Schron; K Handshaw; S Shea; M R Kinney; M Branyon; J Campion; J T Bigger; S C Sylvia; J Duggan; M Stylianou; S Lancaster; D K Ahern; M J Follick
Journal:  Control Clin Trials       Date:  1996-02

Review 6.  The costs of rheumatoid arthritis: absolute, incremental, and marginal estimates.

Authors:  E Yelin
Journal:  J Rheumatol Suppl       Date:  1996-03

7.  Ankylosing spondylitis in women and men: a case-control study.

Authors:  S H Marks; M Barnett; A Calin
Journal:  J Rheumatol       Date:  1983-08       Impact factor: 4.666

8.  Social and economic impacts of four musculoskeletal conditions. A study using national community-based data.

Authors:  J S Kramer; E H Yelin; W V Epstein
Journal:  Arthritis Rheum       Date:  1983-07

9.  Socioeconomic effects of ankylosing spondylitis in females: a comparison of 25 female with 25 male subjects.

Authors:  M A Chamberlain
Journal:  Int Rehabil Med       Date:  1983

10.  Prognosis of inflammatory joint diseases. A three-year follow-up study.

Authors:  M Nissilä; H Isomäki; K Kaarela; P Kiviniemi; J Martio; S Sarna
Journal:  Scand J Rheumatol       Date:  1983       Impact factor: 3.641

View more
  58 in total

Review 1.  New treatment options in ankylosing spondylitis: a role for anti-TNFalpha therapy.

Authors:  J Sieper; J Braun
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

2.  Employment perspectives of patients with ankylosing spondylitis.

Authors:  A M J Chorus; A Boonen; H S Miedema; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2002-08       Impact factor: 19.103

Review 3.  International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.

Authors:  J Braun; T Pham; J Sieper; J Davis; Sj van der Linden; M Dougados; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

4.  Is avoidant coping independent of disease status and stable over time in patients with ankylosing spondylitis?

Authors:  A Boonen; D Van Der Heijde; R Landewé; A Chorus; W Van Lankveld; H Miedema; H Van Der Tempel; S Van Der Linden
Journal:  Ann Rheum Dis       Date:  2004-10       Impact factor: 19.103

Review 5.  Exploring the diversity of conceptualizations of work (dis)ability: a scoping review of published definitions.

Authors:  Valérie Lederer; Patrick Loisel; Michèle Rivard; François Champagne
Journal:  J Occup Rehabil       Date:  2014-06

6.  The relationship between depressive symptoms, illness perceptions and quality of life in ankylosing spondylitis in comparison to rheumatoid arthritis.

Authors:  Thomas Hyphantis; Konstantinos Kotsis; Niki Tsifetaki; Francis Creed; Alexandros A Drosos; André F Carvalho; Paraskevi V Voulgari
Journal:  Clin Rheumatol       Date:  2013-01-18       Impact factor: 2.980

7.  Withdrawal from labour force due to work disability in patients with ankylosing spondylitis.

Authors:  A Boonen; A Chorus; H Miedema; D van der Heijde; R Landewé; H Schouten; H van der Tempel; S van der Linden
Journal:  Ann Rheum Dis       Date:  2001-11       Impact factor: 19.103

8.  Assessment of therapeutic response in ankylosing spondylitis patients undergoing anti-tumour necrosis factor therapy by whole-body magnetic resonance imaging.

Authors:  Martina Karpitschka; Patrizia Godau-Kellner; Herbert Kellner; Annie Horng; Daniel Theisen; Christian Glaser; Bernhard Brandlhuber; Maximilian Reiser; Sabine Weckbach
Journal:  Eur Radiol       Date:  2013-03-15       Impact factor: 5.315

9.  Direct costs of ankylosing spondylitis and its determinants: an analysis among three European countries.

Authors:  A Boonen; D van der Heijde; R Landewé; F Guillemin; M Rutten-van Mölken; M Dougados; H Mielants; K de Vlam; H van der Tempel; S Boesen; A Spoorenberg; H Schouten; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

10.  Patients with ankylosing spondylitis have increased sick leave--a registry-based case-control study over 7 yrs.

Authors:  Britta Strömbeck; Lennart T H Jacobsson; Ann Bremander; Martin Englund; Anders Heide; Aleksandra Turkiewicz; Ingemar F Petersson
Journal:  Rheumatology (Oxford)       Date:  2009-01-22       Impact factor: 7.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.